News
Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...
Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.
2d
Sportschosun on MSNHelicobacter infection 2 to 3 times more likely to have stomach cancer...It's the second most common...According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...
In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without ...
Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...
Dual MAPK inhibition (dMAPKi) as an effective therapeutic strategy for class II BRAF mutant (mt) metastatic melanoma (MM). This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...
OBJECTIVE: This study retrospectively reviewed 46 cases of gastric gastrointestinal stromal tumors treated by endoluminal endoscopic full-thickness resection (EFR) microsurgery in our gastrointestinal ...
GI stromal tumors (GISTs) are neoplasms with widely variable malignant potential that arise from the GI tract, most frequently in the stomach. Their annual incidence is approximately 10 per million. 1 ...
GIST outpatients who received imatinib mesylate (Gleevec, Novartis, Switzerland) between July 2020 and March 2021 at the First Affiliated Hospital of Soochow University were selected. Upon enrollment, ...
Gastrointestinal stromal tumors; Ki-67 antigen; Tumor suppressor protein p53 ... CONCLUSION: The most common site was the small intestine and 80% had a malignant potential justifying the high ...
There are very few reports of gastric cancer (GC) and gastrointestinal stromal tumor (GIST) occurring at the same time in the literature. In particular, the collision of GIST and human epidermal ...
1Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, California. 2Moores Cancer Center, University of California San Diego, La Jolla, San Diego, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results